W
e are seeing more orthopaedic surgeons choosing to use the largest femoral head possible when performing THAs, undoubtedly to prevent against dislocation. Ironically, the founder of the operation, John Charnley, decreased the size of the head from 40 mm to 22 mm to reduce the frictional torque and thicken the cemented acetabulum polyethylene. Thanks to the development of highly crosslinked polyethylene (HXLPE), orthopaedic surgeons are far less concerned about friction [1] than they seem to be about dislocation. But is our increased use of large femoral heads (> 32 mm) as a way of preventing a dislocation an overreaction? That is the question Tsikandylakis and colleagues [7] addressed in the current study comparing 36 mm heads to 32 and 28 mm heads with data from the Combined Scandinavian Registries.
The authors found that 36 mm heads underwent more revisions compared to 32 and 28 mm heads because of loosening, not dislocation [7] . There are two reports of increased loosening of stems with the direct anterior approach in the first 5 years, and the data of this study would be consistent with those previously published [4, 6] . In the current study, 93% of hips with a 36 mm head had a posterior approach, yet that approach was not correlated to increased loosening, which means the increase in loosening was principally driven by the 7% of the hips with 36 mm heads that had anterior approaches [7] . I am curious whether the surgeons used too large a cup for the acetabulum, and as such, increased the risk of an unrecognized acetabular fracture or impingement. Future studies should address this question.
A recently published registry study [1] confirms the finding of increased revision with femoral heads larger than 32 mm at 14 years postoperative in hips with HXLPE. The Australian Registry did not find any difference until after 10 years, but at 14 years, the revision rate was 8.5% (66,973 primary THA) with 36 mm heads and 4.6% (84,157 primary THA) with 32 mm heads. The mean followup of hips with HXLPE was 4.2 years with a cumulative revision rate of 6.2% at 16 years. The leading causes of revision, in order, were dislocation, infection, fracture, and loosening. Noticeably missing as a cause of failure of the HXLPE articulations was osteolysis and wear, which were common with conventional polyethylene [1] .
Where Do We Need To Go?
Orthopaedic surgeons in the United States seem to have developed a habit of using 36 mm heads, and this is not going to change until a definitive study finds that these heads are at a greater risk of failure after 10 years [1] . But why are failures increasing after 10 years in the first place?
Registry studies suggest that 36 mm heads (and all head sizes > 32 mm) have a higher risk of revision after 10 years, although not from wear and osteolysis [1, 7] . We still need studies to examine the reasons for this increase. Spine arthritis and stiffness of the spinopelvic motion could cause late dislocation [5] , but why would loosening be greater in hips with heads larger than 32 mm heads? If this increase is a consequence of taper corrosion, why is there no radiographic evidence of lysis, pseudotumor from fluid, or intraoperative evidence of corrosive products? Are surgeons overreaming the acetabulum to use a larger cup that permits a larger head size? Are the revisions the result of cup loosening or stem loosening [3] ? Because 36 mm heads are now used so commonly, the definitive answers are urgent to educate surgeons about how to make responsible choices regarding femoral head size.
How Do We Get There?
Both the current study [7] and deSteiger and colleagues [1] have findings that raise an important point that needs urgent attention-head sizes > 32 mm have higher failure rates, particularly after 10 years postoperatively. But the reasons for failure have yet to be identified.
I am a strong supporter of joint registries but recognize that there are holes in their data that limit the conclusions we can make. In this era of personalization of joint replacement operations, the registries provide valuable and necessary information but give us only the general picture. For instance, registries can track the performance of implants by revisions according to age, gender, and time from implantation. Registries cannot, however, provide patient detail like activity level, bone type, mental health, marital status, or BMI (although the Australian registry now is collecting BMI for future studies). There is also no technical data on cup size, cup angles, femoral anteversion, combined anteversion, or biomechanical reconstruction.
Hip centers must conduct studies on individual patients that includes data on not just age and gender, but also BMI, activity level, bone type, spinopelvic mobility, and the technical details of implantation including cup size referenced to bony acetabular size, cup positions, combined anteversion, biomechanical reconstruction, and articulation type. It should be noted that the surgeons at these centers are experts with HXLPE and may not be making the same errors that have notably led to failures after 10 years in registries that include all surgeons. This possibility was first reported in deSteiger and colleagues [1] , where the expert's revision rate with HXLPE was 1.9% versus 4.4% in the registry that included all surgeons over the same 10-year period [2] .
But even if studies from the hip centers do not show higher failure with heads $ 36 mm, the criteria used by those surgeons for success in individual patients can be identified. By identifying these criteria, we can educate surgeons on how to improve longevity of operations with larger heads.
Personalized studies should provide us with guidelines necessary for selecting appropriate head sizes for our patients as well as provide data like the acetabular bony size and cup size, combined anteversion of the hip, dislocation risk by patient factors and spinopelvic measurements, and thickness of HXLPE.
